BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 12-Month High at $1.30

BioRestorative Therapies, Inc. (OTCMKTS:BRTXQGet Free Report)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $1.30 and last traded at $1.29, with a volume of 21748 shares changing hands. The stock had previously closed at $1.25.

BioRestorative Therapies Price Performance

The company has a market capitalization of $2.12 billion, a PE ratio of -1.17 and a beta of 102.36. The firm has a 50-day simple moving average of $1.34 and a 200 day simple moving average of $1.54.

BioRestorative Therapies Company Profile

(Get Free Report)

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.

Read More

Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.